TrialAnnals of medicine2025

Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study.

Lele Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.